Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial

Summary

NCT03763136. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Authors	Zhang H, Xue Y, Pan T, Zhu X, Chong H, Xu C, Fan F, Cao H, Zhang B, Pan J, Zhou Q, Yang G, Wang J, Wang DJ
Journal	BMJ open
Publication Date	2022 May 6;12(5):e056264
PubMed	35523485
PubMed Central	PMC9083430
DOI	10.1136/bmjopen-2021-056264

Research Projects

Cell Lines

• (none)